E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/2/2008 in the Prospect News Special Situations Daily.

Usana Health Sciences CEO begins tender offer in $138 million buyout of company

By Lisa Kerner

Charlotte, N.C., June 2 - Gull Holdings, Ltd., through Unity Acquisition Corp., began a $26-per-share tender offer to purchase all outstanding shares of common stock of Usana Health Sciences, Inc. that Gull and other participants in the offer do not already own.

The tender offer is slated to end at midnight ET on June 27 unless extended, according to a Gull Holdings news release.

Total value of the deal is about $138 million.

Gull Holdings, with a 68% stake in the company, is controlled by Usana chairman and chief executive officer Dr. Myron W. Wentz.

Conditions to the tender offer include the availability debt financing to purchase the shares, a majority of shares being tendered and Unity holding at least 90% of the outstanding shares of Usana common stock once the offer is complete.

It was previously reported that Gull Holdings' buyout of Usana would be financed through a $215 million senior secured credit facility consisting of a $15 million revolving credit facility and a $200 million term loan.

Proceeds from the facility also will be used to refinance Usana debt and to fund ongoing working capital requirements.

Ableco Finance LLC is the lead arranger, bookrunner, syndication agent and administrative agent on the facility.

Usana is a nutritional and personal care products company located in Salt Lake City.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.